WILSON KAREN J 4
4 · Angion Biomedica Corp. · Filed Feb 11, 2021
Insider Transaction Report
Form 4
WILSON KAREN J
Director
Transactions
- Conversion
Common Stock
2021-02-09$11.57/sh+18,718$216,567→ 18,718 total - Conversion
Convertible Promissory Note
2021-02-09→ 0 totalExercise: $16.00→ Common Stock
Footnotes (2)
- [F1]The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock.
- [F2]The convertible promissory note ("Convertible Note") had a maturity date of June 1, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share.